What is the recommended dose of cephalexin (cephalexin) for treating soft tissue infections in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin Dosing for Soft Tissue Infections in Adults

The recommended dose of cephalexin for treating soft tissue infections in adults is 500 mg orally every 6 hours (four times daily) for 7-10 days, but this is only appropriate for non-purulent infections caused by methicillin-susceptible Staphylococcus aureus (MSSA) and streptococci. 1, 2, 3

Standard Dosing Regimen

  • 500 mg orally every 6 hours (QID) is the established dose for mild to moderate skin and soft tissue infections in adults 1, 2, 4, 3
  • Treatment duration is typically 7 days, with extension to 10 days based on clinical response 2, 4, 3
  • The FDA-approved adult dosage range is 1-4 grams daily in divided doses 3
  • For less severe infections, an alternative regimen of 500 mg every 12 hours may be used for skin and skin structure infections 3

Critical Coverage Limitations

Cephalexin does NOT cover MRSA - this is the most important clinical pitfall 1, 2, 4

When NOT to Use Cephalexin:

  • Purulent infections (abscesses, carbuncles) with systemic signs or failed initial treatment - use MRSA-active agents instead 1, 2, 4
  • Risk factors for MRSA including: history of MRSA colonization, injection drug use, purulent drainage, or systemic inflammatory response 4
  • Necrotizing infections - these require broad-spectrum IV antibiotics and urgent surgical intervention 4
  • Animal or human bites - use amoxicillin-clavulanate instead for coverage of Pasteurella multocida and anaerobes 1, 2

When Cephalexin IS Appropriate:

  • Non-purulent cellulitis without systemic signs of infection 1, 4
  • Impetigo caused by Staphylococcus and Streptococcus species 1
  • Surgical site infections of trunk or extremity (away from axilla/perineum) 1
  • Penicillin-allergic patients (except those with immediate hypersensitivity reactions) 1, 2, 4

Alternative Agents for MRSA Coverage

If MRSA is suspected, use one of these instead of cephalexin:

  • Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily 1, 4
  • Doxycycline 100 mg twice daily 1, 4
  • Clindamycin 300-450 mg four times daily 1, 4

Special Clinical Situations

  • Recurrent infections: Obtain cultures before starting antibiotics 2
  • Diabetic foot infections: Broader spectrum antibiotics are necessary 2
  • Severe infections or less susceptible organisms: Higher doses may be needed, and if >4 grams daily is required, consider parenteral cephalosporins 3
  • Penicillin allergy advantage: Cephalexin offers better convenience than dicloxacillin due to suspension availability and less frequent dosing 4

Key Clinical Pearls

  • Cephalexin provides excellent coverage against MSSA and streptococci, which are common pathogens in community-acquired soft tissue infections 2, 5
  • Clinical response rates exceed 95% when used appropriately for susceptible organisms 5
  • The drug is well-tolerated with low incidence of side effects (gastrointestinal disturbances in ~7-8% of patients) 6
  • Cross-reactivity is possible in patients with immediate hypersensitivity to penicillins 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cephalexin Dosing and Clinical Considerations for Soft Tissue Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cephalexin Dosing for Adult Skin Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.